Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
Varenicline is a non-nicotinic medication developed as an aid for people who are trying to stop smoking and is the third class of drug, after nicotine replacement therapy and bupropion, to be approved for smoking cessation. Varenicline can be prescribed as a treatment for patients who have never tried medication for smoking cessation as well as for those in whom other treatments have not been successful. Practical suggestions are made for implementing smoking cessation with varenicline.
Tonstad
Serena
S
Loma Linda School of Public Health (LLU-SPH), Norway. stonstad@llu.edu
D000465:Algorithms; D001552:Benzazepines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D018722:Nicotinic Agonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011810:Quinoxalines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D012907:Smoking / Q000188:drug therapy*; D016540:Smoking Cessation / Q000379:methods*; D016896:Treatment Outcome; D000068580:Varenicline
D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline